99% Savings - Buy Just @1 Rs X
Ergolin Injection is a commercial drug that is prescribed in the form of Injection. Primarily, it is used for the treatment of Post Delivery Bleeding.
The right dosage of Ergolin Injection depends on the age, gender, and medical history of the patient. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
Common side effects of Ergolin Injection include Headache, Abdominal Pain, Hypertension. Apart from the aforementioned side effects, Ergolin Injection can also lead to other problems, which have been listed below. Such side effects of Ergolin Injection normally do not last long and go away once the treatment is completed. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, Ergolin Injection's effect is Unknown during pregnancy and Unknown for lactating mothers. It is important to know if Ergolin Injection has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Ergolin Injection related warnings section.
Ergolin Injection can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Ergolin Injection in conditions like High Blood Pressure. The section on Ergolin Injection contraindications lists all such conditions.
Drug interactions for Ergolin Injection have been reported in the medical literature. See below for a complete list.
In addition to the above precautions for Ergolin Injection, it is important to know that it is safe while driving, and is habit-forming.
Ergolin Injection is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult(Female) |
|
Is the use of Ergolin Injection safe for pregnant women?
It is not known what effect Ergolin will have on pregnant women, because no research work has been carried out on this till date.
Is the use of Ergolin Injection safe during breastfeeding?
There is no research available on the side effects of Ergolin in breastfeeding women. Therefore, its impact is unknown.
What is the effect of Ergolin Injection on the Kidneys?
Very few cases of side effects of Ergolin on kidney have been reported.
What is the effect of Ergolin Injection on the Liver?
You may experience side effects on your liver after taking Ergolin. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Ergolin Injection on the Heart?
Ergolin can cause side effects that could harm the heart. So medical advice before taking it is necessary.
If you are suffering from any of the following diseases, you should not take Ergolin Injection unless your doctor advises you to do so -
Is this Ergolin Injection habit forming or addictive?
Ergolin Injection is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can comfortably use machinery or drive after taking Ergolin Injection since it will not make you feel sleepy.
Is it safe?
Ergolin Injection is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, Ergolin Injection is not used to treat mental disorders.
Interaction between Food and Ergolin Injection
Due to a lack of research, nothing can be said about the consequences of taking Ergolin Injection together with food.
Interaction between Alcohol and Ergolin Injection
Due to lack of research, there is no information about the side effects of taking Ergolin Injection with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Methergine® (methylergonovine maleate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 331-332
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 837-839